PBS Website Update - 1 December 2024
Page last updated: 1 December 2024
The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Pharmaceutical Benefits Scheme (PBS) | Changes to PBS listings for Opdualag® and Vyxeos® - 1 December 2024
- New PBS Schedule Data API and API CSV files - 1 December 2024
- PBAC Recommendations for amendments to COVID-19 oral treatment restrictions - 1 December 2024
- Ex-manufacturer price - 1 December 2024
- Formulary Allocations - 1 December 2024
- First New Brand Price Reductions - 1 December 2024
- Drugs subject to Price Disclosure - 1 December 2024
- PBS restriction changes to type 2 diabetes mellitus (T2DM) medicines - 1 December 2024
- Medicine Status Website - 1 December 2024
- Agenda for the March 2025 PBAC meeting – 28 November 2024
- Update on the March 2025 meeting – 28 November 2024
- PBAC Update November 2024 – 28 November 2024
- Review of Authority Required Pharmaceutical Benefits Scheme Listings - 22 November 2024
- Pharmaceutical Benefits Advisory Committee (PBAC) Membership - 22 November 2024
- Drug Utilisation Sub Committee (DUSC) Membership - 22 November 2024
- Economics Sub Committee (ESC) Membership - 22 November 2024
- PBS and RPBS Section 85 Date of Supply Data - 20 November 2024
- PBS subsidy arrangements for estradiol transdermal patches SSSI - 19 November 2024
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 15 November 2024
- PBAC Public Summary Documents (first time decisions not to recommend and deferrals) - July 2024 meeting - 15 November 2024
- PBAC Public Summary Documents – July 2024 meeting - 1 November 2024
- Changes to PBS listings for nurse practitioner prescribing - 1 November 2024
